Interpretable machine learning model for prediction functional cure in chronic hepatitis B patients receiving Peg-IFN
Peiyu Zheng1, Peifeng He2, Ying Guo3
1Department of Infectious Diseases, The First Hospital of Shanxi Medical University, Taiyuan, China; Graduate School of Shanxi Medical University, Taiyuan, China.
Machine learning models predict functional cure for chronic hepatitis B (CHB) patients receiving Peg-IFN treatment. A Support Vector Machine model utilizing week 24 data achieved high accuracy, with a user-friendly website for clinical prediction.
Area of Science:
- Hepatology
- Machine Learning in Medicine
- Virology
Background:
- Functional cure is the primary goal for treating chronic hepatitis B (CHB).
- Predictive models are needed to identify CHB patients likely to achieve functional cure with treatment.
- Pegylated interferon (Peg-IFN) is a key treatment modality for CHB.
Purpose of the Study:
- To develop and validate machine learning (ML) models for predicting functional cure in CHB patients undergoing Peg-IFN therapy.
- To identify optimal time points and clinical variables for predicting functional cure.
- To create a practical tool for clinicians to assess treatment efficacy.
Main Methods:
- Retrospective analysis of 534 CHB patients for model construction and 269 for external validation.
- Development of seven ML models using baseline, week 12, and week 24 data.
- Variable selection via Boruta and LASSO regression, with performance evaluation using AUC, sensitivity, specificity, and F1 score.
Main Results:
- The Support Vector Machine (SVM) model at week 24 demonstrated superior predictive performance (AUC = 0.981) compared to baseline and week 12 strategies.
- Key predictors included age, ALT ratio at week 12, and HBsAg/HBsAg ratio at week 24.
- A web-based dynamic nomogram was developed for convenient clinical prediction.
Conclusions:
- An SVM model effectively predicts functional cure in CHB patients treated with Peg-IFN, particularly when assessed at week 24.
- The developed web tool enables individualized prediction of Peg-IFN therapy efficacy for CHB patients.
- This approach enhances clinical decision-making for CHB management.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
